Literature DB >> 9057167

The Kinmen Neurological Disorders Survey (KINDS): a study of a Chinese population.

H C Liu1, S J Wang, J L Fuh, C Y Liu, K P Lin, C H Lin, P N Wang, K N Lin, H C Wang, H M Chen, R Chang, E B Larson, G S Wu, P Chou, E L Teng.   

Abstract

We conducted an epidemiological study of several neurological disorders among the Chinese aged 50 years or older on the islet of Kinmen. All participants were interviewed and examined by neurologists. From the targeted population of 5,061 individuals, 3,915 (77.4%) of them completed the evaluations. Among the 4,087 individuals with whom face-to-face contact was made, the refusal rate was 4.2%. The disorders of interest were dementia, Parkinson's disease, essential tremor, stroke, transient ischemic attacks, and migraine. Among the 3,915 participants, 366 cases were found with 1 or more of the surveyed neurological disorders on the prevalence day, August 1, 1993, yielding a prevalence of 93.5/1,000. The purpose of this study, the general methodology, and some overall findings are presented in this communication in order to provide a common background for detailed findings on each disorder to be reported separately.

Entities:  

Mesh:

Year:  1997        PMID: 9057167     DOI: 10.1159/000109672

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  10 in total

Review 1.  'Essential tremor' or 'the essential tremors': is this one disease or a family of diseases?

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2013-12-03       Impact factor: 3.282

2.  Prevalence of essential tremor in Araihazar, Bangladesh: a population-based study.

Authors:  Elan D Louis; Danella Hafeman; Faruque Parvez; Roy N Alcalay; Tariqul Islam; Abu Baker Siddique; Tajul Islam Patwary; Stephanie Melkonian; Maria Argos; Diane Levy; Habibul Ahsan
Journal:  Neuroepidemiology       Date:  2011-01-19       Impact factor: 3.282

Review 3.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

4.  Long-term risk of dementia following acute kidney injury: A population-based study.

Authors:  Chih-Chin Kao; Che-Hsiung Wu; Chun-Fu Lai; Tao-Min Huang; Hsi-Hsien Chen; Vin-Cent Wu; Likwang Chen; Mai-Szu Wu; Kwan-Dun Wu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Oct-Dec

5.  Validation of the Taiwanese Version of ACE-III (T-ACE-III) to Detect Dementia in a Memory Clinic.

Authors:  Ruan-Ching Yu; Naaheed Mukadam; Narinder Kapur; Joshua Stott; Chaur-Jong Hu; Chien-Tai Hong; Cheng-Chang Yang; Lung Chan; Li-Kai Huang; Gill Livingston
Journal:  Arch Clin Neuropsychol       Date:  2022-02-22       Impact factor: 3.448

Review 6.  Systematic review of the prevalence and incidence of Parkinson's disease in Asia.

Authors:  Weerasak Muangpaisan; Hiroyuki Hori; Carol Brayne
Journal:  J Epidemiol       Date:  2009-10-03       Impact factor: 3.211

7.  A walk-in screening of dementia in the general population in Taiwan.

Authors:  Chun-Hung Chen; Ling-Chun Wang; Tzu-Chiao Ma; Yuan-Han Yang
Journal:  ScientificWorldJournal       Date:  2014-05-04

8.  Could Wearable and Mobile Technology Improve the Management of Essential Tremor?

Authors:  Jean-Francois Daneault
Journal:  Front Neurol       Date:  2018-04-19       Impact factor: 4.003

9.  A Nationwide Survey of Dementia Prevalence in Long-Term Care Facilities in Taiwan.

Authors:  Yi-Hui Kao; Chih-Cheng Hsu; Yuan-Han Yang
Journal:  J Clin Med       Date:  2022-03-11       Impact factor: 4.241

10.  How Common is Essential Tremor? Update on the Worldwide Prevalence of Essential Tremor.

Authors:  Elan D Louis; Morgan McCreary
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-07-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.